Skip to main content
OpenTrials
Completed

NCT Number: NCT03901443

Survey on Itch in Outpatients of a University Clinic

This study is to investigate the pruriception (i.e. the perception of the character and intensity of itch), the impact of itch on quality of life, the response to itch and the subjective efficacy and preferences of the different treatment options among patients with different skin diseases. Better insights into these aspects might help to optimize itch treatment in clinical Settings.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Itch Pathological Conditions, Signs and Symptoms Pruritus Signs and Symptoms Skin Diseases Skin Manifestations Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Dermatology, University Hospital Basel

Basel, 4031, Switzerland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • outpatients suffering from itch

Exclusion criteria

  • outpatients (suffering from itch) not willing or able to participate

Treatment and study plan

Survey on itch

Other

self-administered patient questionnaire regarding the different aspects of itch

Primary outcomes

  1. itch intensity

    Time frame: single time point assessment at baseline

    Questions regarding itch perception (NRS 0-10; 0 = no itch, 10 = worst imaginable itch) experienced at the moment, within the last 7 days, within the last month

  2. itch perception

    Time frame: single time point assessment at baseline

    Questions regarding situations in which the itch is especially bad (multiple choice options regarding day time, daily situations, season); objective assessment in which respondents are asked to select answers from the choices offered as a list

  3. impact of itch on quality of life

    Time frame: single time point assessment at baseline

    Questions regarding strength of impact of itch on quality of life (NRS 0-10; 0 = no impact, 10 = extreme)

  4. quality of sleep

    Time frame: single time point assessment at baseline

    Questions regarding sleep disturbance by itch (Does itch disturb the patient's sleep and/or sleep of other persons? (yes/no))

  5. days missing at work

    Time frame: single time point assessment at baseline

    Approximate number of days missing at work due to itch within last 6 months

  6. helpfulness of common itch therapies

    Time frame: single time point assessment at baseline

    Questions regarding helpfulness of common itch therapies (NRS 0-10; 0 = no reduction in itch, 10

    = complete reduction of itch; additionally free text options to indicate specific creams, tablets or alternative medicine)

  7. preferred treatment options

    Time frame: single time point assessment at baseline

    Questions regarding preferred treatment options (NRS 0- 10; 0 = unimportant, 10 = most important; including additional free text option)

Sponsors and collaborators

Lead sponsor

University Hospital, Basel, Switzerland

Other

Registry information

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Apr 3, 2019
Registry last updated
Apr 8, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.